eltoprazine has been researched along with glutamic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, SM; Girdlestone, D; Lopez, A; Olivier, B; Roberts, MH | 1 |
| Arcuri, L; Brugnoli, A; Mercatelli, D; Morari, M; Paolone, G | 1 |
2 other study(ies) available for eltoprazine and glutamic acid
| Article | Year |
|---|---|
The actions of the novel anti-aggressive drug eltoprazine on central neurones in the anaesthetised rat.
Topics: Action Potentials; Aggression; Animals; Brain Stem; Evoked Potentials; Glutamates; Glutamic Acid; Male; Medulla Oblongata; Motor Neurons; Neurons; Piperazines; Rats; Rats, Inbred Strains; Serotonin; Spinal Cord | 1990 |
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Corpus Striatum; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Functional Laterality; gamma-Aminobutyric Acid; Gene Expression Regulation; Glutamic Acid; Levodopa; Male; MAP Kinase Signaling System; Motor Activity; Oxidopamine; Parkinson Disease; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Time Factors | 2015 |